Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Can a $1B IPO attract leery investors on HKEX? WuXi AppTec is set to find out
7 years ago
Financing
BioHaven hopes to soothe Chinese headaches with Shanghai subsidiary
7 years ago
At the center of a global tempest, Jiankui He defends editing the genes of 2 newborns
7 years ago
In a landmark first, Chinese scientist claims birth of genetically modified babies — and all hell breaks loose
7 years ago
Seeking an edge in the global I/O race, Alphamab Oncology loads up $100M-plus from marquee backers
7 years ago
Financing
CStone braves the HKEX with late-stage plans brewing for newly beefed up I/O pipeline
7 years ago
Financing
Innovent, Eli Lilly cite a new success for their PD-1 in lung cancer, with a likely pioneering approval in China looming
7 years ago
R&D
Finally! Innovent hikes on Hong Kong debut amid cloudy market sentiments
7 years ago
Financing
Feds charge a group of Genentech vets with another scheme to steal trade secrets — this time to help a Taiwanese biotech
7 years ago
WuXi dives into computational drug discovery, launches New York-based JV with Schrödinger
7 years ago
Financing
AI
Terns scores $80M in Series B financing led by Vivo, OrbiMed
7 years ago
Financing
A photo log of my week in Shanghai, hosting the first annual US-China Biopharma Innovation and Investment Summit
7 years ago
Hong Kong IPO delivers $421M to Innovent as another one of China's biotech unicorns hauls in big money
7 years ago
Financing
Innovent to seek $400M-plus on Hong Kong IPO, reports say; will it revive biotech's fortunes on HKEX?
7 years ago
Financing
#BIIS18 Interview: OrbiMed Asia's Jonathan Wang on his upbringing, deciding against a consulting career, blunt advice for Chinese entrepreneurs, and more
7 years ago
People
Genscript rebounds on HKEX with staunch defense of Legend Biotech's CAR-T data integrity
7 years ago
Scathing short attack from an obscure source accuses Nanjing Legend of manipulating CAR-T data — Genscript shares nosedive
7 years ago
With new $10.6B fund, Hillhouse Capital sets the stage for splashy Asia-focused biotech deals
7 years ago
Financing
Startups
WuXi AppTec files for public listing in Hong Kong four months after explosive Shanghai IPO
7 years ago
Financing
Outsourcing
Another scientist pleads guilty for his role in a scheme to sell GSK's trade secrets in China
7 years ago
People
Pharma
Sanofi swaps top execs with Bayer, triggering a reorganization that puts China in the headlights
7 years ago
People
Chinese pharma powerhouse Hansoh joins fledgling biotechs in the Hong Kong IPO line
7 years ago
Financing
Chi-Med, Eli Lilly score a landmark approval in China for the first new cancer drug developed in China
7 years ago
Pharma
GlaxoSmithKline scientist cops a guilty plea in scheme to sell the pharma giant's drug research in China
7 years ago
First page
Previous page
22
23
24
25
26
27
28
Next page
Last page